Eledon Pharmaceuticals (ELDN) Non Operating Income (2014 - 2026)
Eledon Pharmaceuticals posted quarterly Non Operating Income of $1.1 million for Q1 2026, down 20.65% year-on-year from $1.4 million in Q1 2025, and up 6.78% on a QoQ basis from $1.0 million in Q3 2025.
Eledon Pharmaceuticals (ELDN) has 12 years of Non Operating Income data on file, last reported at $1.1 million in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income fell 20.65% year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $4.8 million (up 0.82% YoY), and the FY2024 full-year result was $3.9 million, up 46.75% from the prior year.
- Non Operating Income for Q1 2026 stood at $1.1 million, up from $1.0 million in the prior quarter.
- Across five years, Non Operating Income topped out at $1.4 million in Q4 2024 and bottomed at -$5000.0 in Q1 2022.
- The 5-year median for Non Operating Income is $812000.0 (2023), against an average of $741125.0.
- The widest annual swing landed in 2022, when Non Operating Income tumbled 200.0%; it then surged 6860.0% in 2023.
- A 5-year view of Non Operating Income shows it stood at $304000.0 in 2022, then surged by 134.21% to $712000.0 in 2023, then surged by 102.11% to $1.4 million in 2024, then declined by 27.24% to $1.0 million in 2025, then rose by 6.78% to $1.1 million in 2026.
- The last three Non Operating Income figures came in at $1.1 million (Q1 2026), $1.0 million (Q3 2025), and $1.2 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 444,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 201.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -46.98 Mn |
| 10 | Eledon Pharmaceuticals | 419.90 Mn | 203.87 Mn | - | 1.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.12 Mn |
| Sep 30, 2025 | 1.05 Mn |
| Jun 30, 2025 | 1.22 Mn |
| Mar 31, 2025 | 1.41 Mn |
| Dec 31, 2024 | 1.44 Mn |
| Sep 30, 2024 | 1.04 Mn |
| Jun 30, 2024 | 869,000.00 |
| Mar 31, 2024 | 574,000.00 |
| Dec 31, 2023 | 712,000.00 |
| Sep 30, 2023 | 849,000.00 |
| Jun 30, 2023 | 775,000.00 |
| Mar 31, 2023 | 338,000.00 |
| Dec 31, 2022 | 304,000.00 |
| Sep 30, 2022 | 127,000.00 |
| Jun 30, 2022 | 36,000.00 |
| Mar 31, 2022 | -5,000.00 |
| Sep 30, 2021 | 3,000.00 |
| Jun 30, 2021 | -1,000.00 |
| Mar 31, 2021 | 5,000.00 |
| Dec 31, 2020 | 40,000.00 |
| Sep 30, 2020 | 4,000.00 |
| Jun 30, 2020 | 5,000.00 |
| Mar 31, 2020 | 30,000.00 |
| Dec 31, 2019 | 23,000.00 |
| Sep 30, 2019 | 27,000.00 |
| Jun 30, 2019 | -4,000.00 |
| Mar 31, 2019 | -6,000.00 |
| Dec 31, 2018 | 3,000.00 |
| Sep 30, 2018 | 3,000.00 |
| Mar 31, 2018 | -11,000.00 |
| Dec 31, 2017 | -5,000.00 |
| Sep 30, 2017 | -5,000.00 |
| Jun 30, 2017 | 4,000.00 |
| Mar 31, 2017 | 11,000.00 |
| Dec 31, 2016 | -48,000.00 |
| Sep 30, 2016 | -418,000.00 |
| Jun 30, 2016 | -70,000.00 |
| Dec 31, 2014 | 53,000.00 |
| Sep 30, 2014 | 34,000.00 |